Cytarabine
- Product NDC
- 61703-304
- 11-digit product format
- 617030304
- Labeler code
- 61703
- Product ID
- 61703-304_412ed3cc-fefa-4665-9f00-cf118fd55b6f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CYTARABINE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA072945
- Marketing category
- ANDA
- Marketing start
- 1994-02-28
- Substance
- CYTARABINE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cytarabine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYTARABINE | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 04079A1RDZ |
| Rxcui | 240416 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61703-304-36 | Cytarabine | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 16 |
| 61703-304-36 | Cytarabine | 25 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 25 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CYTARABINE | ACTIVE INGREDIENT | 04079A1RDZ | CYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 5 | |
| CYTARABINE | ACTIVE MOIETY | 04079A1RDZ | CYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 5 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | CYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 5 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61703-304 | CYTARABINE INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | Current NDC, Legacy NDC, 2 package rows | 20240805_21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61703-304-36 | 61703030436 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) / 25 mL in 1 VIAL, MULTI-DOSE | 1994-02-28 | 0000-00-00 | No | No | Current |